UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
1376
DELISTED
New Relic, Inc.
NEWR
| $1.57M | ﹤0.01% |
+45,100
| New | +$1.48M |
|
1377
Fulton Financial
FULT
$4.67B
| $1.57M | ﹤0.01% |
126,891
+3,200
| +3% | +$37.7K |
|
1378
Primerica
PRI
$10.2B
| $1.57M | ﹤0.01% |
28,898
+1,000
| +4% | +$51K |
|
|
FSP
1379
Franklin Street Properties
FSP
$47.1M
| $1.56M | ﹤0.01% |
127,497
+9,100
| +8% | +$109K |
|
|
ANFI
1380
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $1.55M | ﹤0.01% |
108,249
+42,817
| +65% | +$623K |
|
1381
SM Energy
SM
$6.88B
| $1.55M | ﹤0.01% |
40,177
-5,980
| -13% | -$300K |
|
|
HRC
1382
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.54M | ﹤0.01% |
33,867
+2,200
| +7% | +$97.5K |
|
|
JNS
1383
DELISTED
Janus Capital Group Inc
JNS
| $1.54M | ﹤0.01% |
95,564
+2,200
| +2% | +$33.1K |
|
1384
Manhattan Associates
MANH
$11.1B
| $1.54M | ﹤0.01% |
37,800
+1,300
| +4% | +$49.7K |
|
1385
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $1.54M | ﹤0.01% |
83,343
+42,010
| +102% | +$889K |
|
1386
Belden
BDC
$5.05B
| $1.54M | ﹤0.01% |
19,499
+700
| +4% | +$49.6K |
|
1387
Winnebago Industries
WGO
$885M
| $1.54M | ﹤0.01% |
70,592
+58,493
| +483% | +$1.34M |
|
1388
Atara Biotherapeutics
ATRA
$74.3M
| $1.53M | ﹤0.01% |
+2,292
| New | +$1.4M |
|
|
WGL
1389
DELISTED
Wgl Holdings
WGL
| $1.53M | ﹤0.01% |
28,061
+800
| +3% | +$38.8K |
|
1390
Penske Automotive Group
PAG
$14.2B
| $1.53M | ﹤0.01% |
31,099
+6,000
| +24% | +$274K |
|
1391
Maximus
MMS
$3.06B
| $1.52M | ﹤0.01% |
27,798
+1,600
| +6% | +$77.8K |
|
1392
Wolverine World Wide
WWW
$1.56B
| $1.52M | ﹤0.01% |
51,696
+2,900
| +6% | +$80.3K |
|
1393
Darling Ingredients
DAR
$9.62B
| $1.52M | ﹤0.01% |
83,796
+2,100
| +3% | +$38K |
|
1394
Viavi Solutions
VIAV
$10B
| $1.52M | ﹤0.01% |
194,832
+5,274
| +3% | +$39.3K |
|
|
SPIL
1395
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $1.52M | ﹤0.01% |
201,100
| – | – |
|
|
ALX
1396
Alexander's
ALX
$1.39B
| $1.51M | ﹤0.01% |
3,454
| – | – |
|
|
PLCM
1397
DELISTED
POLYCOM INC
PLCM
| $1.51M | ﹤0.01% |
111,692
+800
| +0.7% | +$10.2K |
|
1398
MaxLinear
MXL
$6.37B
| $1.51M | ﹤0.01% |
203,200
| – | – |
|
|
AAN.A
1399
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $1.5M | ﹤0.01% |
49,254
+1,500
| +3% | +$45.8K |
|
1400
Carpenter Technology
CRS
$27.7B
| $1.5M | ﹤0.01% |
30,380
+4,400
| +17% | +$212K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.